CIBC Private Wealth Group
TMO icon

CIBC Private Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History

CIBC Private Wealth Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$468M Sell
806,898
-28,067
-3% -$15.9M 0.79% 22
2025
Q3 		$405M Buy
834,965
+249,171
+43% +$116M 0.69% 30
2025
Q2 		$238M Sell
585,794
-15,961
-3% -$6.67M 0.42% 67
2025
Q1 		$252M Sell
601,755
-974
-0.2% -$528K 0.53% 53
2024
Q4 		$328M Sell
602,729
-18,187
-3% -$10M 0.6% 44
2024
Q3 		$384M Sell
620,916
-5,652
-0.9% -$3.35M 0.69% 34
2024
Q2 		$336M Sell
626,568
-8,491
-1% -$4.86M 0.63% 39
2024
Q1 		$367M Sell
635,059
-7,842
-1% -$4.4M 0.72% 30
2023
Q4 		$341M Sell
642,901
-18,252
-3% -$8.83M 0.72% 32
2023
Q3 		$335M Sell
661,153
-21,251
-3% -$11.3M 0.79% 30
2023
Q2 		$356M Sell
682,404
-11,165
-2% -$6.02M 0.78% 30
2023
Q1 		$64.3M Sell
693,569
-8,428
-1% -$4.75M 0.14% 149
2022
Q4 		$354M Buy
701,997
+31,233
+5% +$16.5M 1.19% 20
2022
Q3 		$340M Buy
670,764
+10,395
+2% +$5.82M 0.92% 27
2022
Q2 		$359M Sell
660,369
-64
-0% -$35.2K 0.93% 24
2022
Q1 		$390M Buy
660,433
+2,280
+0.3% +$1.31M 0.85% 27
2021
Q4 		$439M Buy
658,153
+7,675
+1% +$4.79M 0.91% 23
2021
Q3 		$372M Buy
650,478
+2,536
+0.4% +$1.39M 0.86% 27
2021
Q2 		$327M Sell
647,942
-102,551
-14% -$48.4M 0.75% 31
2021
Q1 		$343M Sell
750,493
-63,924
-8% -$30.5M 0.86% 26
2020
Q4 		$379M Sell
814,417
-293,303
-26% -$138M 1% 21
2020
Q3 		$489M Buy
1,107,720
+427,229
+63% +$177M 1.5% 7
2020
Q2 		$247M Sell
680,491
-338,893
-33% -$114M 1.2% 19
2020
Q1 		$289M Sell
1,019,384
-10,960
-1% -$3.46M 1.24% 15
2019
Q4 		$335M Buy
1,030,344
+282
+0% +$85.5K 1.09% 16
2019
Q3 		$300M Sell
1,030,062
-4,901
-0.5% -$1.4M 1.06% 17
2019
Q2 		$304M Buy
1,034,963
+91,414
+10% +$25.2M 1.07% 18
2019
Q1 		$258M Buy
943,549
+8,504
+0.9% +$2.12M 1% 19
2018
Q4 		$209M Buy
935,045
+12,983
+1% +$3.05M 0.93% 22
2018
Q3 		$225M Buy
922,062
+3,031
+0.3% +$697K 0.85% 24
2018
Q2 		$190M Buy
919,031
+17,336
+2% +$3.68M 0.78% 27
2018
Q1 		$186M Buy
901,695
+28,391
+3% +$5.96M 0.81% 26
2017
Q4 		$166M Buy
873,304
+162,532
+23% +$31.1M 0.7% 34
2017
Q3 		$134M Buy
710,772
+144,924
+26% +$26.2M 0.61% 45
2017
Q2 		$98.7M Buy
565,848
+1,472
+0.3% +$247K 0.62% 53
2017
Q1 		$86.7M Buy
564,376
+1,563
+0.3% +$239K 0.54% 63
2016
Q4 		$79.4M Buy
562,813
+14,405
+3% +$2.12M 0.53% 64
2016
Q3 		$87.2M Buy
548,408
+10,652
+2% +$1.64M 0.61% 55
2016
Q2 		$79.5M Buy
537,756
+10,340
+2% +$1.53M 0.58% 60
2016
Q1 		$74.7M Buy
527,416
+204,117
+63% +$27.4M 0.58% 60
2015
Q4 		$45.9M Buy
323,299
+10,131
+3% +$1.35M 0.36% 81
2015
Q3 		$38.3M Buy
313,168
+281,484
+888% +$36.7M 0.32% 86
2015
Q2 		$4.11M Buy
31,684
+2,170
+7% +$283K 0.03% 308
2015
Q1 		$3.96M Buy
29,514
+511
+2% +$65.9K 0.03% 311
2014
Q4 		$3.63M Sell
29,003
-747
-3% -$90.8K 0.03% 311
2014
Q3 		$3.62M Buy
29,750
+980
+3% +$119K 0.03% 313
2014
Q2 		$3.4M Buy
28,770
+6,850
+31% +$806K 0.03% 314
2014
Q1 		$2.68M Buy
+21,920
New +$2.61M 0.02% 334

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC Private Wealth Group's TMO Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q4 2025, selling an estimated $15.9M and leaving 806,898 shares worth $468M. The position accounts for 0.79% of the portfolio, ranked #22.

CIBC Private Wealth Group first reported a position in TMO in Q1 2014 and has held it in 48 quarters since. The position peaked at $489M in Q3 2020. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • CIBC Private Wealth Group held 806,898 shares of Thermo Fisher Scientific worth $468M as of Q4 2025.
  • CIBC Private Wealth Group sold 28,067 Thermo Fisher Scientific shares in Q4 2025, an estimated $15.9M.
  • Thermo Fisher Scientific made up 0.79% of CIBC Private Wealth Group's portfolio in Q4 2025, its #22 holding.
  • CIBC Private Wealth Group first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 48 quarters since.
  • CIBC Private Wealth Group's Thermo Fisher Scientific position peaked at $489M in Q3 2020.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.